Breakthrough Treatment for Degenerative Diseases
- We have an experimental drug that may prevent or cure over 30 cureless, devastating diseases, including Alzheimer’s, Parkinson’s, Huntington’s, Lou Gehrig’s, type-2 diabetes, and many others that have a common underlying mechanism.
- The drug has shown improvement in 7 different disease models without side effects!
We are a team of scientists led by Gal
Bitan, Ph.D., an Associate professor at UCLA with 15 years of experience in studying degenerative diseases, and 30 collaborating research groups around the world.
The basic research has been
funded by foundation and government grants supporting Alzheimer’s,
Parkinson’s, and ALS research. We now need a considerable amount of money that
will allow us to initiate clinical trials.
- Please make a contribution as small or large as you can, and forward our plea to your network. You never know who might have a relative or a friend who may be affected by one of these horrible diseases.
We are asking
for your money so that we can work even harder to find a cure that will benefit
all of humanity.
- If everyone who has been affected by these diseases, contributes one dollar, we will have what we need to move forward quickly towards clinical trials.
According to the Alzheimer’s Association, Alzheimer’s disease is the 6th leading cause of death in the US, and while the top 5 causes are declining, including breast cancer, prostate cancer, heart disease, stroke, and HIV, Alzheimer’s numbers are steadily rising and have increased by 68% between 2000–2010. In fact, a recent study suggests that the number of deaths associated with Alzheimer’s is much larger than previously thought and the disease may be the 3rd leading cause of death.
The list includes more than 30 diseases and many additional conditions, including HIV
infection, spinal cord injury, traumatic brain injury, and certain cancers. To
know if any of these affect you or someone close to your heart, see our Comprehensive List of Amyloidoses and Conditions Affected by Abnormal Protein Aggregation.
Our drug, called a "molecular tweezer," is the first of its kind for which we know exactly how and why it works.
If you want to learn more, check out where the molecular tweezers came from and the news items about their action on Parkinson’s and Alzheimer’s. You can also find many of our scientific publications on Dr. Bitan’s website.
The challenge is that the molecular tweezers work in a way that is entirely different from any drug developed before. Innovative ideas often are met with resistance. It is hard to believe today, but there were times in which people wrote scientific articles “proving” that a machine will never be able to carry its own weight in the air. This has nothing to do with how smart or experienced the person is. As put so eloquently by Tolstoy:
“The most difficult subjects can be explained to the most slow-witted man if he has not formed any idea of them already; but the simplest thing cannot be made clear to the most intelligent man if he is firmly persuaded that he knows already, without a shadow of doubt, what is laid before him.”
— Leo Tolstoy 1897
If everyone who knows someone affected by these diseases contributes one dollar, we will have what we need to move forward as quickly as possible towards clinical trials!